Is the excessive inhibition of matrix metalloproteinases (MMPs) by potent synthetic MMP inhibitors (MMPIs) desirable in periodontitis and other inflammatory diseases? That is: 'Leaky' MMPIs vs excessively efficient drugs

Oral Diseases

Volumn 11, Issue 6, 2005, Pages 408-409

  Sorsa, T ^a   Golub, L M ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; COLLAGENASE; DOXYCYCLINE; MATRIX METALLOPROTEINASE INHIBITOR;

CONNECTIVE TISSUE; GINGIVITIS; INFLAMMATORY DISEASE; LETTER; PERIODONTITIS; PRIORITY JOURNAL;

ANIMALS; DOXYCYCLINE; HUMANS; MATRIX METALLOPROTEINASES; PERIODONTITIS; PHENYLALANINE; PROTEASE INHIBITORS; RATS; THIOPHENES;

EID: 26944479901     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2005.01160.x     Document Type: Letter

References (13)

1. Bjornsson MJ, Havemose-Poulsen A, Stoltze K, Holmstrup P (2004). Influence of the matrix metalloproteinase inhibitor Batimastat (BB-94) on periodontal bone destruction in Sprague-Dawley rats. J Periodontal Res 39: 269-274.
2. Emingil G, Atilla G, Sorsa T, Luoto H, Kirilmaz L, Baylas H (2004). The effect of adjunctive low-dose doxycycline therapy on clinical para and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis. J Periodontol 75: 106-115.
3. Golub LM, Ciancio S, Ramamurthy NS, Leung M, McNamara TF (1990). Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodont Res 25: 321-330.
4. Golub LM, Evans RT, McNamara TF, Lee HM, Ramamurthy NS (1994). A non-antimicrobial tetracycline inhibits gingival matrix metalloproteinases and bone loss in Porphyromonas gingivalis-induced periodontitis in rats. Ann NY Acad Sci 732: 96-111.
5. Golub LM, Lee HM, Greenwald RA, Ryan ME, Salo T, Sorsa T et al (1997). A matrix metalloproteinase inhibitor reduces bone type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Inflam Res 46: 310-319.
6. Golub LM, McNamara TF, Ryan ME et al (2001). Adjunctive treatment with sub-antimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 28: 146-156.
7. Gomes BC, Golub LM, Ramamurthy NS (1984). Tetracyclines inhibit parathyroid hormone-induced bone resorption in organ culture. Experientia 40: 1273-1275.
8. Ingman T, Tervahartiala T, Ding Y, Tschesche H, Haerian D, Kinane D et al (1996). Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 23: 1127-1132.
9. Mantyla P, Stenman M, Kinane DF et al. (2003). Gingival crevicular fluid collagenase-2 (MMP-8) test stick for chair-s monitoring of periodontitis. J Periodontal Res 38: 436-439.
10. Overall CM and Lopez-Otin C (2002). Strategies for MMP inhibition in cancer: innovations for the post-trial. Nat Rev Cancer 2: 657-672.
11. Owen CA, Hu Z, Lopez-Otin C, Shapiro SD (2004). Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagen serpinase. J Immunol 172: 7791-7803.
12. Ramamurthy NS, Rifkin BR, Greenwald RA, Turner G, Golub LM, Vernillo AT (2002). Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of six chemically-modified tetracyclines. J Periodontol 73: 726-734.
13. Sorsa T, Tjäderhane L, Salo T (2004). Matrix metalloproteinases (MMPs) in oral diseases. Oral Diseases 10: 311-318.